Connection

Abdullah Assiri to Sustained Virologic Response

Back to Details
This is a "connection" page, showing publications Abdullah Assiri has written about Sustained Virologic Response.
Abdullah Assiri
Connection Strength
0.118
Sustained Virologic Response
  1. Treatment efficacy of ledipasvir/sofosbuvir for 8 weeks in non-cirrhotic chronic hepatitis C genotype 4 patients. Saudi J Gastroenterol. 2019 Jan-Feb; 25(1):55-60.
    View in: PubMed
    Score: 0.041
  2. Real life efficacy of ledipasvir/sofosbuvir in hepatitis C genotype 4-infected patients with advanced liver fibrosis and decompensated cirrhosis. J Infect. 2018 06; 76(6):536-542.
    View in: PubMed
    Score: 0.039
  3. High Efficacy of ombitasvir/paritaprevir/ritonavir plus dasabuvir in hepatitis C genotypes 4 and 1-infected patients with severe chronic kidney disease. Liver Int. 2018 08; 38(8):1395-1401.
    View in: PubMed
    Score: 0.039
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.